StockData
DuPont de Nemours, Inc. logo

DuPont de Nemours, Inc. (DD) company profile

DDNYSEPlastic Materials, Synth Resins & Nonvulcan ElastomersFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3058% above fair value
$155.61−1.27 (-0.81%)

Close on Nov 11, 2026Market cap $21.01BP/E 345.8Yield 2.76%

About DuPont de Nemours

Plastic Materials, Synth Resins & Nonvulcan Elastomers, SIC 2821

DuPont de Nemours, Inc. provides advanced technology solutions across healthcare, water, construction, and diverse industrial sectors. Its business is organized into two primary reportable segments: Healthcare & Water Technologies and Diversified Industrials. Offerings include specialized medical packaging, parts for medical devices, protective garments, and water purification technologies, alongside building materials, insulation, structural adhesives, lubricants, and engineered parts. The company serves global customers across biopharma, medical device manufacturing, municipal water facilities, construction, aerospace, and automotive industries.

The company operates globally with subsidiaries in approximately 50 countries and manufacturing sites across around 20 countries. Its international footprint spans North America, Asia Pacific, EMEA, and Latin America, supported by a global workforce of roughly 15,000 employees and distribution through direct sales and independent distributors worldwide. The provided text notes DuPont as a Delaware corporation, but does not state the city or location of its headquarters.

Summary of the business section of DuPont de Nemours's latest annual report, written by StockData.

Company profile

Company

Legal name
DuPont de Nemours, Inc.
Founded
2015
Headquarters
Wilmington, DE
Address
974 Centre Road, Building 730 19805
Phone
(302) 295-5783
Employees
15,000, Dec 31, 2025
Industry
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Philadelphia, Pennsylvania

Stock & identifiers

Ticker
DD
Exchange
NYSE
Shares outstanding
135M, Jul 31, 2026
Public float
$12.00B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
1-for-3 reverse, Jun 24, 2026; 1-for-3 reverse, Aug 6, 2019; 3-for-1, Jun 19, 2000; 3-for-2, Nov 21, 1989; 2-for-1, Jun 8, 1976; 2-for-1, May 10, 1973
SEC CIK
1666700
CUSIP
26614N201
ISIN
US26614N2018
FIGI
BBG00BN961G4
Share class FIGI
BBG00BN961H3
LEI
5493004JF0SDFLM8GD76
EIN
81-1224539

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Lori KochCEO, Director115,715
Erik T. HooverSVP & General Counsel38,798
Madeleine G. BarberVP Chief Accounting Officer1,793
Beth FerreiraPresident, Diversified Indstrl6,560
Antonella B. FranzenSVP & CFO68,809
Christopher RaiaSenior Vice President & CHRO85,911
Matthew S. AbbottSVP, CIO12,446
Jeroen BloemhardPresident, HC and Water Tech24,770
Steven P. LarrabeeSVP & CIO45,511
Michael G. GossController20,279
Jon D. KempPresident, ElectronicsCo.150,070
Leland WeaverPresident, Water & Protection51,782
Edward D. BreenDirector127,276
Frederick M. LoweryDirector13,862
Donald G. MacphersonDirector2,196
Alexander M. CutlerDirector25,155
Amy G. BradyDirector23,781
James A. LicoDirector10,839
Kurt B. McMakenDirector8,258
Pont Eleuthere I. duDirector42,963
Ruby R. ChandyDirector25,444
Terrence R. CurtinDirector38,467
Kristina M. JohnsonDirector10,836
Luther C. Kissam IvDirector25,998
Steven SterinDirector21,389

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Edward DBreen
$7.51M$834.81K$4.13M$169$190
FY2025
Lori DKoch
$16.13M$18.32M$4.13M$169$190
FY2024$15.68M$15.44M$5.14M$131$176
FY2023
Edward Breen
$19.85M$24.51M$3.24M$129$150
FY2023
Edward DBreen
$19.85M$24.51M$3.24M$129$150
FY2022$25.58M$19.10M$3.28M$113$127

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Lori D. Koch
Chief Executive Officer
$1.24M–$12.55M$1.90M$446.73K$16.13M+28%
Antonella B. Franzen
Senior Vice President, Chief Financial Officer
$741.67K–$3.14M$872.85K$188.69K$4.94M+33%
Jeroen P. Bloemhard
President, Healthcare & Water Technologies
$545.83K$400.00K$750.04K$474.38K$84.35K$2.25M–
Erik T. Hoover
Senior Vice President, General Counsel
$687.50K–$2.00M$708.40K$134.26K$3.53M+16%
Christopher P. Raia
Senior Vice President, Chief Human Resources Officer
$566.67K–$1.75M$494.62K$104.93K$2.92M–
Edward D. Breen
Former Executive Chairman
$833.33K–$5.00M$1.27M$403.29K$7.51M-52%
Jon D. Kemp
Former President, Electronics and Industrial
$641.67K–$5.00M–$129.24K$5.77M+78%
Leland G. Weaver
Former President, Water and Protection
$505.86K–$1.75M$507.39K$2.58M$5.34M+71%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, the Company employed approximately 15,000 people worldwide, approximately 1,700 of which are dedicated to the Aramids Business.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?